Table 1 Summary and baseline of all included studies
Characteristics of All included Studies | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Author, year | Type of Study | Country | Patients (n) (comp/control) | Age (mean) (comp/control) | male, n (comp/control) | mean follow up | stent length, mean (comp/control) | Number of stents, mean (comp/control) | Reference vessel diameter, mean (comp/control) | Lesion length, mean (comp/control) | Diameter stenosis, mean (comp/control) | Medical conditions, n (comp/control) | Target vessel, n (comp/control) | Procedural Characteristics, n (comp/control) | |||||||||||||||
Previous MI | Previous CABG | Previous PCI | DM | HTN | Dyslipidaemia | Current smoker | PAD | LM | LCX | RCA | LAD | Ostial location | Bifurcation | Moderate/severe tortuosity | Severe calcification | B2/C lesion | 7Â F guiding catheter | ||||||||||||
Wang 2022 | Retrospective study | China | 16/313 | (60.87/59.70) | (16/284) | 30.22 month | (105.5/90.69) | (3.14/2.50) | NA | NA | NA | (4/79) | (0/15) | (10/206) | (8/95) | (14/184) | (5/89) | (3/70) | NA | (0/1) | (0/7) | (12/185) | (4/120) | NA | NA | (14/184) | (16/157) | NA | NA |
Pagnotta 2010 | Retrospective study | Italy | 45/603 | (70/63) | (29/506) | NA | NA | NA | (2.75/ 2.79) | (26/22) | NA | (24/341) | (18/87) | NA | (20/250) | (34/512) | NA | (13/126) | NA | NA | (8/134) | (18/241) | (13/158) | (0/56) | NA | NA | (14/141) | NA | NA |
Abdel-Wahab 2013 | randomized active-controlled superiority trial | Germany | 120/120 | 70.5/71.8 | 86/96 | 75.3 months | 27.7/25.2 | 1./1.3 | 3.1/3.1 | 20.6 /18.5 | 81.5/80 | 38/29 | 9/15 | 44/39 | 33/32 | 106/95 | 91/87 | 24/16 | NR | 3/2 | 7/22 | 35/41 | 101/111 | 27/31 | 72/82 | 67/83 | 65/86 | 137/152 | 122/50 |
Abdel-Wahab 2018 | randomized trial | Germany | 100/100 | 75/74.8 | 75/77 | 77.1 months | 35.41/35.63 | 1.71/1.52 | 3.31/3.25 | 30.07/29.81 | 83.54/83.02 | 22/21 | 13/6 | 55/47 | 34/33 | 93/93 | 69/68 | 9/15 | NR | 20/15 | 16/16 | 40/32 | 61/78 | 35/40 | 61/55 | 44/49 | 100/104 | 129/137 | 111/130 |
Azzalini 2017 | Retrospective study | Spain, Canada, Italy | 35/968 | 68.9/64.6 | 31/841 | 2 years | 72.8/68.4 | 2/2.2 | NR | NR | NR | NR | NR | NR | 19/351 | 27/711 | 32/765 | 9/205 | NR | NR | 3/180 | 17/509 | 15/275 | NR | NR | NR | 30/413 | NR | NR |
Huang 2018 | Retrospective study | Taiwan | 26/259 | 71.1/66.4 | 23/215 | 3.4 years | 40.7/34.2 | NR | NR | NR | NR | NR | NR | NR | 13/158 | 19/223 | NR | 4/11 | NR | 1/2 | 1/10 | 14/137 | 11/110 | NR | NR | NR | NR | NR | NR |
Ayoub 2023 | Retrospective study | Germany | 193/2596 | 70.33/65.73 | 156/2143 | 1 year | 50.55/54.18 | 2.19/1.73 | NR | NR | NR | 66/995 | 65/417 | NR | 84/775 | 178/2229 | 178/2333 | 21/519 | NR | NR | 37/554 | NR | 40/699 | 14/174 | NR | 46/538 | 166/942 | NR | 117/889 |